VivoSim Labs, Inc. Cost of Goods Sold (Deprecated 2018-01-31)
VivoSim Labs, Inc. (VIVS) reported Cost of Goods Sold (Deprecated 2018-01-31) of $134.00 thousand for the 83-month period ending 2014-03-31, per its 10-K filed 2014-06-10.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2014-06-10
- VivoSim Labs, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $70.42K.
- VivoSim Labs, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $0.00.
- VivoSim Labs, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $0.00.
- VivoSim Labs, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2011-03-31 was $50.58K.
- VivoSim Labs, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2011 was $121.00K.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 59 month | Cost of Goods Sold (Deprecated 2018-01-31) 62 month | Cost of Goods Sold (Deprecated 2018-01-31) 65 month | Cost of Goods Sold (Deprecated 2018-01-31) 68 month | Cost of Goods Sold (Deprecated 2018-01-31) 71 month | Cost of Goods Sold (Deprecated 2018-01-31) 74 month | Cost of Goods Sold (Deprecated 2018-01-31) 77 month | Cost of Goods Sold (Deprecated 2018-01-31) 80 month | Cost of Goods Sold (Deprecated 2018-01-31) 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $134.00K 10-K · filed 2014-06-10 | ||||||||||||
| 2013-12-31 | $134.00K 10-Q · filed 2014-02-06 | ||||||||||||
| 2013-09-30 | $134.00K 10-Q · filed 2013-11-08 | ||||||||||||
| 2013-06-30 | $134.00K 10-Q · filed 2013-08-09 | ||||||||||||
| 2013-03-31 | $134.00K 10-KT · filed 2013-05-24 | ||||||||||||
| 2012-12-31 | $134.00K 10-K · filed 2013-03-15 | ||||||||||||
| 2012-09-30 | $133.61K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $133.61K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $133.61K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $70.42K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | $70.42K derived: sum of 2 quarters · filed 2014-06-10 | $70.42K derived: sum of 3 quarters · filed 2014-06-10 | $121.00K 10-K · filed 2014-06-10 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $50.58K 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $50.58K 10-Q · filed 2012-08-14 | |||||||||||
| 2011-03-31 | $50.58K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |